Goldman Sachs Group Inc/The/ US38141G1040 /
6/4/2024 5:08:46 PM | Chg. - | Volume | Bid4:00:21 PM | Ask4:00:19 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
416.50EUR | - | 2 Turnover: 833 |
425.30Bid Size: 45 | 426.40Ask Size: 45 | 136.65 bill.EUR | - | - |
GlobeNewswire
3:00 PM
Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June...
GlobeNewswire
2:00 PM
Fulcrum Therapeutics to Participate in the Goldman Sachs’ 45th Annual Global Healthcare Conference
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference
GlobeNewswire
1:00 PM
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:53 AM
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
GlobeNewswire
6/5
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
6/5
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
6/5
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
6/5
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
GlobeNewswire
5/9
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
4/11
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties
GlobeNewswire
2/23
New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Busines...
GlobeNewswire
10/26/2023
New to The Street's Leadership Series Airs Two Interviews, Sam Reese, CEO, Vistage Worldwide, Inc., ...